Author Question: Which of the following best describes forcible entry and detainer action? A) It is the legal action ... (Read 34 times)

Mr3Hunna

  • Hero Member
  • *****
  • Posts: 536
Which of the following best describes forcible entry and detainer action?
 A) It is the legal action taken by a tenant in case of nondisclosure by the landlord.
 B) It is the summary action brought by a landlord on previous tenants.
 C) It is the legal action taken by a tenant for wrongful eviction.
 D) It is the summary action brought by a landlord to regain possession.

Question 2

In Vande Zande v. State of Wisconsin Dept. of Administration, the court held that an employer's refusal to allow a disabled employee to work at home was:
 A) a violation of the ADA.
 B) a discriminatory action.
 C) not a violation of the ADA.
 D) a violation of the NLRA.



mmpiza

  • Sr. Member
  • ****
  • Posts: 354
Answer to Question 1

D

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The Centers for Disease Control and Prevention has released reports detailing the deaths of infants (younger than 1 year of age) who died after being given cold and cough medications. This underscores the importance of educating parents that children younger than 2 years of age should never be given over-the-counter cold and cough medications without consulting their physicians.

Did you know?

Aspirin may benefit 11 different cancers, including those of the colon, pancreas, lungs, prostate, breasts, and leukemia.

Did you know?

Medications that are definitely not safe to take when breastfeeding include radioactive drugs, antimetabolites, some cancer (chemotherapy) agents, bromocriptine, ergotamine, methotrexate, and cyclosporine.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library